🏥ONCOLOGY CAPABILITY
Resistance Prediction: Level 3 of CSI Journey
Predict When Chemo Might Stop Working
Once you have CSI score and treatment history, unlock resistance prediction. Post-treatment pathway profiling (validated AUROC 0.714-0.750, n=11) captures tumor evolution and predicts when to retest CSI.
3
Level 3 of CSI Journey: KILL CHAIN + SPE
What resistance class is active right now? Monitors 10 resistance classes validated across 680 patients from 6 independent datasets with temporal ctDNA modeling.
Data Required
Post-treatment pathway profiling + resistance markers + ctDNA
Unlocks
- •10 resistance class detection (BRCA reversion, ABCB1 efflux, SLFN11, lineage plasticity)
- •6 independent datasets (ARIEL, Patch, Christie, TCGA-OV, Abbott, MSK-SPECTRUM)
- •Temporal ctDNA resistance modeling (27 paired ARIEL profiles)
RETROSPECTIVE TESTED680 patients, 10 resistance classes, 6 datasets, SLFN11 33.6% detection
Content for this tab is coming soon.
API Endpoints
/predict_gene_essentiality/predict_chromatin_accessibility/predict_protein_functionality_change